The Importance of Accurate Patient Matching for AI Projects
Artificial intelligence (AI) is revolutionizing healthcare by enhancing workflows, enabling earlier diagnoses, and paving the way for personalized care. However, …
Biopharma Insights
Survey Highlights Critical Need for AI Adoption in Regulatory Affairs Amid Unsustainable Workloads
New research commissioned by ArisGlobal, a provider of life sciences technology solutions, reveals that surging regulatory workloads are forcing life …
What will be the key trends in AI innovation in the Pharmaceutical Industry in 2025?
The pharmaceutical industry is undergoing transformation thanks to artificial intelligence (AI) in particular GenAI. From drug discovery and manufacturing to …
Cautious Optimism in 2024 for Healthcare M&A
2024 was supposed to mark the start of a significant comeback for healthcare mergers and acquisitions (M&A). Yet with the …
AI Is Key to Democratizing Drug Discovery
The global drug development landscape is bustling, with over 20,000 biotechs competing for investor attention. Now more than ever, having …
Key Trends in Aging Research: Where Are We Now?
Over the past decade, aging research has transitioned from foundational biological studies, including a landmark introduction of 9 hallmarks of …
Global Pharma R&D Investments Surpass $276 Billion Annually, Exceeding Previous Estimates
A recent study, titled Comprehensive Measurement of Biopharmaceutical R&D Investment, published in Nature Reviews Drug Discovery, reveals that global pharmaceutical …
The Promise of Chatbots in Clinical Trials
In the rapidly changing field of clinical trials, chatbots are becoming valuable tools for data analysis. These AI-driven conversational agents …
Even 10 Minutes Matter in Cancer Research
A recent study conducted by Indivumed Therapeutics highlights a crucial, yet often overlooked, factor in cancer research: the cold ischemia …
How Enterprise Architecture is Powering Digital Transformation in Healthcare
The healthcare industry is confronting critical challenges including a systemic labour shortage, rising costs (estimated to grow to its highest …
UK-based Laverock Therapeutics Expands Gene-Silencing Technology to Tackle Multiple Disease Areas
Laverock Therapeutics, a UK company based at the Stevenage Bioscience Catalyst, is advancing its programmable gene-silencing platform, GEiGS, aimed at …
Microbiome, Aging, and the Synthetic Immune System: A New Frontier in Geroscience
What does aging have in common with pathogens like bacteria and viruses? And how does the quest to tackle antimicrobial …